Correcting RAG1 Deficiency Using CRISPR/CAS9

被引:0
|
作者
de Bruin, L. Ott [1 ]
Lee, Y. N. [1 ]
Musunuru, K. [2 ]
Notarangelo, L. D. [1 ]
机构
[1] Boston Childrens Hosp, Boston, MA USA
[2] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ESID-0632
引用
收藏
页码:S183 / S183
页数:1
相关论文
共 50 条
  • [21] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [22] GENE EDITING IN CHONDROCYTES USING CRISPR/CAS9
    Gibson, G.
    Yang, M.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S2 - S3
  • [23] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
    Zhang, Song
    Shen, Jiangtao
    Li, Dali
    Cheng, Yiyun
    THERANOSTICS, 2021, 11 (02): : 614 - 648
  • [24] Rag1 Deficiency Impairs Arteriogenesis in Mice
    Kumaraswami, Konda
    Arnholdt, Christoph
    Deindl, Elisabeth
    Lasch, Manuel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [25] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
  • [26] Cas9 Targeting and the CRISPR Revolution
    Barrangou, Rodolphe
    SCIENCE, 2014, 344 (6185) : 707 - 708
  • [28] CRISPR/Cas9 as a Mutagenic Factor
    Shumega, Andrey R.
    Pavlov, Youri I.
    Chirinskaite, Angelina V.
    Rubel, Aleksandr A.
    Inge-Vechtomov, Sergey G.
    Stepchenkova, Elena I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [29] Photoactivatable CRISPR/Cas9 System
    E. A. Akhmetova
    V. M. Golyshev
    I. P. Vokhtantcev
    M. I. Meschaninova
    A. G. Venyaminova
    D. S. Novopashina
    Russian Journal of Bioorganic Chemistry, 2021, 47 : 496 - 504
  • [30] CRISPR screens beyond Cas9
    Darren J. Burgess
    Nature Reviews Genetics, 2020, 21 : 273 - 273